Commissioning and validation of the Elekta One GPUMCD algorithm for an Elekta VersaHD linear accelerator

Samuel D Rusu; Blake R Smith; Grace H Hutchinson; Jun Hsuang Jen; Daniel E Hyer

doi:10.1002/acm2.70540

Back

Commissioning and validation of the Elekta One GPUMCD algorithm for an Elekta VersaHD linear accelerator

Journal article

Open access

Peer reviewed

Commissioning and validation of the Elekta One GPUMCD algorithm for an Elekta VersaHD linear accelerator

Samuel D Rusu, Blake R Smith, Grace H Hutchinson, Jun Hsuang Jen and Daniel E Hyer

Journal of applied clinical medical physics, Vol.27(3), e70540

03/2026

DOI: 10.1002/acm2.70540

PMID: 41860318

Files and links (1)

url

https://doi.org/10.1002/acm2.70540View

Published (Version of record) Open Access

Abstract

The purpose of this work was to commission and validate GPUMCD, a GPU-accelerated Monte Carlo dose calculation engine for c-arm Elekta linear accelerators (linac). This algorithm was recently released for clinical implementation in the Elekta One Treatment Planning System (v6.2.3, EOP). A GPUMCD beam model was generated for all photon energies of a VersaHD linac (6X, 6FFF, 10X, 10FFF, 18X). A validated version of the Monaco Commissioning Utility was used to compare calculated percent depth dose (PDD) profiles as well as lateral profiles for open fields against measurements. An adapted MPPG 5.b methodology was used to verify point-doses and 3D dose distributions in homogeneous and heterogeneous media using the ArcCheck, solid water, the CIRS ZEUS phantom, and the IROC HN and spine phantoms. The average agreement between measured and calculated PDDs and beam profiles using a local 2% dose difference (DD) in the high dose region for fields greater than 5 × 5 cm was 98.4% ± 2.3% for all energies. Using a 2% DD and 2 mm distance-to-agreement (DTA) gamma criteria for all fields using a 5% dose threshold yielded an agreement of 99.9% ± 0.5%. For open fields, GPUMCD reduced the calculation time by 93% as compared to X-ray voxel Monte Carlo (XVMC) using the same hardware. All MPPG 5.b. recommended testing was within the suggested tolerance limits. All plan measurements passed at the recommended gamma criteria. GPUMCD heterogeneity agreement and point dose measurements were found to agree within 3%. The GPUMCD algorithm in EOP was successfully tested and commissioned for clinical use for the VersaHD linac.

Algorithms

Humans

Monte Carlo Method

Neoplasms - radiotherapy

Particle Accelerators - instrumentation

Phantoms, Imaging

Photons

Radiotherapy Dosage

Radiotherapy Planning, Computer-Assisted - methods

Radiotherapy, Intensity-Modulated - methods

Details

Title: Subtitle: Commissioning and validation of the Elekta One GPUMCD algorithm for an Elekta VersaHD linear accelerator
Creators: Samuel D Rusu - University of Iowa Hospitals and Clinics
Blake R Smith - University of Iowa
Grace H Hutchinson - Department of Radiation Oncology, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA
Jun Hsuang Jen - University of Iowa Hospitals and Clinics
Daniel E Hyer - University of Iowa Hospitals and Clinics
Resource Type: Journal article
Publication Details: Journal of applied clinical medical physics, Vol.27(3), e70540
DOI: 10.1002/acm2.70540
PMID: 41860318
NLM abbreviation: J Appl Clin Med Phys
ISSN: 1526-9914
eISSN: 1526-9914
Publisher: Wiley
Language: English
Date published: 03/2026
Academic Unit: Roy J. Carver Department of Biomedical Engineering; Radiation Oncology
Record Identifier: 9985147089402771

Metrics

1 Record Views